Paper Details

  1. Home
  2. Paper Details

Recent advances in the pharmacological management of constipation predominant irritable bowel syndrome.

Author: FichnaJakub, NiewinnaKarolina, ZielińskaAnna

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
ReviewAn article that critically examines existing research on a particular topic and summarizes the current state of knowledge in the field.

Overview

Irritable bowel syndrome with constipation (IBS-C) is a common and distressing condition. This review discusses the pathophysiology and current treatment options for IBS-C, highlighting promising new pharmacological agents in development.
Paper Details　
Original Abstract of the Article :
<b>Introduction</b>: Irritable bowel syndrome (IBS) is a complex functional gut disorder that typically manifests in early adult years. More than a third of IBS patients are diagnosed with predominant constipation subtype (IBS-C). This syndrome has a distressing impact on the quality of life and is...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1080/14656566.2019.1688784

データ提供：米国国立医学図書館（NLM）

Constipation-Predominant Irritable Bowel Syndrome: A Focus on Pharmacological Management

This research provides a comprehensive overview of the pharmacological management of constipation-predominant irritable bowel syndrome (IBS-C), a common gastrointestinal disorder. The authors delve into the pathophysiology of constipation in IBS-C and discuss current treatment options, highlighting the latest findings that may lead to novel pharmacological approaches. The research emphasizes the need for effective therapies to address the debilitating symptoms of IBS-C and improve patients' quality of life.

Pharmacological Options for IBS-C: A Growing Arsenal of Treatments

This research highlights the progress made in developing pharmacological treatments for IBS-C. The authors discuss a range of medications, including linaclotide, lubiprostone, plecanatide, and tegaserod, and explore the mechanisms by which they act to alleviate constipation symptoms. The research emphasizes the need for further research to develop even more effective and safe medications for managing IBS-C.

IBS-C: A Complex and Challenging Condition

IBS-C is a complex and often debilitating condition, affecting millions of people worldwide. This research underscores the importance of finding effective treatment options to improve patients' quality of life and reduce the impact of this condition. As a researcher, I find it important to understand the complexities of gastrointestinal disorders and the challenges faced by individuals with these conditions. Just as a desert oasis provides a respite from the harsh environment, we must strive to find treatments that offer relief and improve the quality of life for patients with IBS-C.
Date :
  1. Date Completed 2020-02-03
  2. Date Revised 2020-02-03
Further Info :

Pubmed ID

31724881

DOI: Digital Object Identifier

10.1080/14656566.2019.1688784

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.